lundi 29 septembre 2014

Chemotherapy: Rolapitant reduces nausea and vomiting in phase III trial

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial.

Chemotherapy: Rolapitant reduces nausea and vomiting in phase III trial

Aucun commentaire:

Enregistrer un commentaire